49 related articles for article (PubMed ID: 3362859)
1. Identification and characterization of an activating TrkA deletion mutation in acute myeloid leukemia.
Reuther GW; Lambert QT; Caligiuri MA; Der CJ
Mol Cell Biol; 2000 Dec; 20(23):8655-66. PubMed ID: 11073967
[TBL] [Abstract][Full Text] [Related]
2. Dimerization mediated through a leucine zipper activates the oncogenic potential of the met receptor tyrosine kinase.
Rodrigues GA; Park M
Mol Cell Biol; 1993 Nov; 13(11):6711-22. PubMed ID: 8413267
[TBL] [Abstract][Full Text] [Related]
3. Mediation of NGF-stimulated extracellular matrix invasion by the human melanoma low-affinity p75 neurotrophin receptor: melanoma p75 functions independently of trkA.
Herrmann JL; Menter DG; Hamada J; Marchetti D; Nakajima M; Nicolson GL
Mol Biol Cell; 1993 Nov; 4(11):1205-16. PubMed ID: 8305739
[TBL] [Abstract][Full Text] [Related]
4. Different structural alterations upregulate in vitro tyrosine kinase activity and transforming potency of the erbB-2 gene.
Segatto O; King CR; Pierce JH; Di Fiore PP; Aaronson SA
Mol Cell Biol; 1988 Dec; 8(12):5570-4. PubMed ID: 2907606
[TBL] [Abstract][Full Text] [Related]
5. trkB, a novel tyrosine protein kinase receptor expressed during mouse neural development.
Klein R; Parada LF; Coulier F; Barbacid M
EMBO J; 1989 Dec; 8(12):3701-9. PubMed ID: 2555172
[TBL] [Abstract][Full Text] [Related]
6. Clonal populations of the mouse mammary cell line, COMMA-D, which retain capability of morphogenesis in vivo.
Danielson KG; Knepper JE; Kittrell FS; Butel JS; Medina D; Durban EM
In Vitro Cell Dev Biol; 1989 Jun; 25(6):535-43. PubMed ID: 2544547
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of activation of the human trk oncogene.
Coulier F; Martin-Zanca D; Ernst M; Barbacid M
Mol Cell Biol; 1989 Jan; 9(1):15-23. PubMed ID: 2538716
[TBL] [Abstract][Full Text] [Related]
8. The actin domain of Gardner-Rasheed feline sarcoma virus inhibits kinase and transforming activities.
Sugita K; Gutkind JS; Katamine S; Kawakami T; Robbins KC
J Virol; 1989 Apr; 63(4):1715-20. PubMed ID: 2538651
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic activation of the human trk proto-oncogene by recombination with the ribosomal large subunit protein L7a.
Ziemiecki A; Müller RG; Fu XC; Hynes NE; Kozma S
EMBO J; 1990 Jan; 9(1):191-6. PubMed ID: 2403926
[TBL] [Abstract][Full Text] [Related]
10. A human cellular sequence implicated in trk oncogene activation is DNA damage inducible.
Ben-Ishai R; Scharf R; Sharon R; Kapten I
Proc Natl Acad Sci U S A; 1990 Aug; 87(16):6039-43. PubMed ID: 1696715
[TBL] [Abstract][Full Text] [Related]
11. The trk tyrosine protein kinase mediates the mitogenic properties of nerve growth factor and neurotrophin-3.
Cordon-Cardo C; Tapley P; Jing SQ; Nanduri V; O'Rourke E; Lamballe F; Kovary K; Klein R; Jones KR; Reichardt LF
Cell; 1991 Jul; 66(1):173-83. PubMed ID: 1649007
[TBL] [Abstract][Full Text] [Related]
12. Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor.
Rong S; Bodescot M; Blair D; Dunn J; Nakamura T; Mizuno K; Park M; Chan A; Aaronson S; Vande Woude GF
Mol Cell Biol; 1992 Nov; 12(11):5152-8. PubMed ID: 1406687
[TBL] [Abstract][Full Text] [Related]
13. Frequent generation of oncogenes by in vitro recombination of TRK protooncogene sequences.
Oskam R; Coulier F; Ernst M; Martin-Zanca D; Barbacid M
Proc Natl Acad Sci U S A; 1988 May; 85(9):2964-8. PubMed ID: 3362859
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic activation of the tyrosine kinase domain of the human trk proto-oncogene by fusion to a cell adhesion molecule.
Albor A; Thraves PJ; Dritschilo A; Notario V
Oncogene; 1996 Oct; 13(8):1755-63. PubMed ID: 8895522
[TBL] [Abstract][Full Text] [Related]
15. Human trk oncogenes activated by point mutation, in-frame deletion, and duplication of the tyrosine kinase domain.
Coulier F; Kumar R; Ernst M; Klein R; Martin-Zanca D; Barbacid M
Mol Cell Biol; 1990 Aug; 10(8):4202-10. PubMed ID: 1695324
[TBL] [Abstract][Full Text] [Related]
16. The trk family of oncogenes and neurotrophin receptors.
Lamballe F; Klein R; Barbacid M
Princess Takamatsu Symp; 1991; 22():153-70. PubMed ID: 1844238
[TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of conserved residues in the tyrosine kinase domain of the human trk oncogene.
Mitra G
Oncogene; 1991 Dec; 6(12):2237-41. PubMed ID: 1837350
[TBL] [Abstract][Full Text] [Related]
18. Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells.
Comoglio PM
EXS; 1993; 65():131-65. PubMed ID: 8380735
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
